TABLE 1.
Univariate Cox regression analysis of all clinical indicators and the five-gene risk group.
| Clinical indicator | Beta | HR | 95% CI for HR | Wald.test | P value |
| PROT | −0.21 | 0.81 | 0.57–1.2 | 1.2 | 0.27 |
| AGE | 0.025 | 1 | 1–1 | 8.8 | 0.0029* |
| SEX | −0.05 | 0.95 | 0.7–1.3 | 0.1 | 0.75 |
| RACE | 0.041 | 1 | 0.65–1.7 | 0.03 | 0.86 |
| ISOTYPE | −0.01 | 0.99 | 0.88–1.1 | 0.03 | 0.87 |
| B2M | 0.73 | 2.1 | 1.4–3.1 | 12 | 0.00051* |
| CRP | 0.33 | 1.4 | 1–1.9 | 4.1 | 0.044* |
| CREAT | 0.5 | 1.6 | 1.2–2.3 | 9.4 | 0.0021* |
| LDH | 0.0063 | 1 | 1–1 | 51 | 9.60E-13* |
| ALB | −0.71 | 0.49 | 0.35–0.7 | 16 | 7.00E-05* |
| HGB | −0.38 | 0.68 | 0.49–0.95 | 5.3 | 0.022* |
| ASPC | 0.01 | 1 | 1–1 | 10 | 0.0015* |
| BMPC | 0.0094 | 1 | 1–1 | 10 | 0.0016* |
| MRI | 0.017 | 1 | 1–1 | 14 | 0.00016* |
| CPS1 | −0.05 | 0.95 | 0.7–1.3 | 0.1 | 0.75 |
| CPR1 | −0.23 | 0.79 | 0.58–1.1 | 2.2 | 0.13 |
| Cyto_Abn | 0.82 | 2.3 | 1.7–3.1 | 28 | 1.10E-07* |
| Riskgroup | 1.2 | 3.2 | 2.3–4.6 | 45 | 2.10E-11* |
HR, hazard ratio; CI, confidence interval; and *p < 0.05.